StockNews.AISignal intelligence
Company intelligence

COCH

Envoy Medical, Inc. · NASDAQ · Healthcare

Price$7.15+0.70% · +$0.05
Market cap55.34MEquity value
P / E-9.1Trailing ratio
Volume49.31KLatest session
Market data

COCH price chart

TradingView
Related signals
1 min delayed

Browse public COCH signals with their source context and measured market impact. Open any signal for its permanent analysis page.

COCHOct 12, 2026-0.43% since signal

Envoy Medical Advances Acclaim PMA with Second FDA Module, Targeting 2027 Completion

Envoy Medical disclosed the second PMA module submission for the Acclaim cochlear implant, advancing a four-module rolling process. With two modules down, the company expects the final module with clinical data by end-Q2 2027, keeping the pivotal trial and U.S. commercialization timeline intact. While the Breakthrough Device Designation adds regulatory optimism, continued feedback cycles and capital needs remain key risks.

View signal analysis
Research

Company intelligence